HR Technology Conference & Exposition® Returns with New Programs to Showcase Emerging Technologies
04 juin 2024 07h00 HE
|
HR Technology Conference & Exposition (R)
HR Technology Conference & Exposition® Returns with New Programs to Showcase Emerging Technologies
Department of Digital Transformation and Ogden’s Catalyst Accelerator Announce Challenge Statement and Open Applications for Fall 2024 Cohort
03 juin 2024 16h29 HE
|
Catalyst Accelerator
Ogden, UT, June 03, 2024 (GLOBE NEWSWIRE) -- The Ogden Catalyst Accelerator is pleased to announce the opening of applications for its Fall 2024 cohort, focused on addressing the critical challenge...
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
03 juin 2024 08h00 HE
|
Genesis Global
Genesis Global announced new technologies and changes in its engagement model to drive broad industry adoption of its application platform.
USI Insurance Services Launches PATH, a Proprietary Technology-Enabled Risk Control Platform
03 juin 2024 08h00 HE
|
USI Insurance Services
VALHALLA, N.Y., June 03, 2024 (GLOBE NEWSWIRE) -- USI Insurance Services (“USI”), a world leader in risk management, employee benefit and retirement plan consulting, today announced the launch of...
Alberta Cancer Foundation announces new Breakthrough Fund recipient, driving commercial success of cancer research breakthroughs
31 mai 2024 12h00 HE
|
Alberta Cancer Foundation
Alberta Cancer Foundation announces new Breakthrough Fund recipient, driving commercial success of cancer research breakthroughs
Local startup Oncobiotix
Mountain America Credit Union’s Christine Ebert Recognized Among Utah Business 30 Women to Watch
31 mai 2024 10h00 HE
|
Mountain America Credit Union
SANDY, Utah, May 31, 2024 (GLOBE NEWSWIRE) -- Christine Ebert, vice president of project management at Mountain America Credit Union, was recently recognized by Utah Business as one of the 30 Women...
Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
30 mai 2024 18h01 HE
|
Novartis Pharma AG
Patients treated with remibrutinib experienced improvements in weekly urticaria activity scores (UAS7) observed as early as Week 1 and sustained to 1 year (Week 52)1Remibrutinib, an oral Bruton’s...
Incorta launches the first Operational GenAI with leading RAG and LLM providers
28 mai 2024 09h12 HE
|
Incorta, Inc.
FOSTER CITY, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Incorta, a leading operational lakehouse, today announces the launch of Operational GenAI, an unlimited and enterprise GenAI solution built on...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
25 mai 2024 06h15 HE
|
Novartis Pharma AG
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction...